CSPG4 and glioblastoma: NG2-expressing cells in GBM are associated with significant cell proliferation, invasiveness, migration, and resistance to chemotherapeutic agents and radiotherapy, which raises interest in the area of targeted therapy, as this could slow or even hinder tumoral growth and improve therapeutic response [173,174].